Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial.
| Publicado en: | Lancet Vol. 361; no. 9375; pp. 2114 - 2118 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Lancet
6/21/2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106884545&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106884545 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 6/21/2003 vid: 361 iid: 9375 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 106884545 106884545 2003153043 10.1016/s0140-6736(03)13721-x NLM12826434 106884545 ppf: 2114 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. aug: au: Hughes R Goldkorn A Masoli M Weatherall M Burgess C Beasley R affil: Green Lane Hospital, Auckland, New Zealand sug: subj: Albuterol Administration and Dosage Asthma Drug Therapy Magnesium Sulfate Administration and Dosage Administration, Inhalation Adolescence Adult Aged Asthma Physiopathology Bronchodilator Agents Administration and Dosage Chemotherapy, Adjuvant Chi Square Test Clinical Trials Confidence Intervals Correlation Coefficient Descriptive Statistics Forced Expiratory Volume Middle Age Nebulizers and Vaporizers New Zealand Placebos Therapeutic Use Funding Source Human Adolescent: 13-18 years Adult: 19-44 years Aged: 65+ years Middle Aged: 45-64 years pubtype: Academic Journal doctype: clinical trial research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|